MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 189 filers reported holding MYRIAD GENETICS INC in Q4 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $14 | -99.9% | 973 | -18.3% | 0.00% | – |
| Q3 2022 | $22,000 | +15.8% | 1,191 | +8.9% | 0.00% | – |
| Q2 2022 | $19,000 | -34.5% | 1,094 | -7.8% | 0.00% | – |
| Q1 2022 | $29,000 | +52.6% | 1,187 | +72.0% | 0.00% | – |
| Q4 2021 | $19,000 | -51.3% | 690 | -44.3% | 0.00% | – |
| Q3 2021 | $39,000 | +225.0% | 1,238 | +209.5% | 0.00% | – |
| Q2 2021 | $12,000 | -45.5% | 400 | -46.3% | 0.00% | – |
| Q1 2021 | $22,000 | +214.3% | 745 | +86.2% | 0.00% | – |
| Q4 2020 | $7,000 | +16.7% | 400 | -19.2% | 0.00% | – |
| Q3 2020 | $6,000 | +50.0% | 495 | +25.3% | 0.00% | – |
| Q2 2020 | $4,000 | -66.7% | 395 | -54.4% | 0.00% | – |
| Q1 2020 | $12,000 | -68.4% | 867 | -38.1% | 0.00% | – |
| Q4 2019 | $38,000 | +22.6% | 1,400 | +27.3% | 0.00% | – |
| Q3 2019 | $31,000 | – | 1,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 5,809,799 | $205,667,000 | 4.45% |
| Tieton Capital Management, LLC | 146,650 | $5,191,000 | 3.90% |
| KESTREL INVESTMENT MANAGEMENT CORP | 614,275 | $21,745,000 | 2.97% |
| Provident Investment Management, Inc. | 375,032 | $13,276,000 | 2.70% |
| Summit Street Capital Management, LLC | 77,810 | $2,754,000 | 2.46% |
| RATIONAL ADVISORS LLC | 253,200 | $8,963,000 | 2.17% |
| S&T BANK/PA | 393,446 | $13,928,000 | 2.08% |
| Euclidean Technologies Management, LLC | 63,684 | $2,254,000 | 2.05% |
| Grace Capital | 220,769 | $7,815,000 | 1.76% |
| AIMZ Investment Advisors, LLC | 57,850 | $2,048,000 | 1.75% |